KCNN4 and ischemic stroke: While it of course has long been known that KCa3.1 is expressed in T cells and that KCa3.1 blockers can inhibit T cell functions [11, 64], it had not previously been demonstrated that KCa3.1 inhibitors reduce T cell infiltration in the setting of ischemic stroke.